Holdings of Franklin Biotechnology Discovery Fund
Franklin Strategic Series · Original filing · Compare with another fund · Report an error
- Net assets
- 1B $ including 982.8M $ in equities, 94.9 %
- Positions
- 86 in 9 countries
- Top ten
- 37.8 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Jazz Pharmaceuticals PLC | 283,073 | 57.5M $ | 5.55 % |
| 2 | Amgen Inc | 141,974 | 49.2M $ | 4.75 % |
| 3 | Gilead Sciences Inc | 368,999 | 48.3M $ | 4.66 % |
| 4 | Regeneron Pharmaceuticals, Inc. | 61,019 | 43.1M $ | 4.16 % |
| 5 | Vertex Pharmaceuticals Inc | 97,436 | 41.6M $ | 4.02 % |
| 6 | Argenx SE | 48,962 | 38.3M $ | 3.69 % |
| 7 | Ascendis Pharma A/S | 129,742 | 29.8M $ | 2.87 % |
| 8 | Insmed Inc | 214,314 | 29.2M $ | 2.82 % |
| 9 | Revolution Medicines Inc | 202,430 | 29.2M $ | 2.82 % |
| 10 | Praxis Precision Medicines Inc | 81,426 | 26M $ | 2.51 % |
| 11 | Spyre Therapeutics Inc | 323,584 | 24.1M $ | 2.33 % |
| 12 | Dianthus Therapeutics Inc | 270,799 | 23.8M $ | 2.30 % |
| 13 | Guardant Health Inc | 248,985 | 21.7M $ | 2.09 % |
| 14 | Oruka Therapeutics Inc | 316,426 | 21.6M $ | 2.09 % |
| 15 | Mirum Pharmaceuticals Inc | 215,190 | 20.9M $ | 2.02 % |
| 16 | PTC Therapeutics Inc | 319,652 | 20.8M $ | 2.01 % |
| 17 | AstraZeneca PLC | 102,531 | 19.2M $ | 1.85 % |
| 18 | Neurocrine Biosciences Inc | 135,273 | 17.8M $ | 1.72 % |
| 19 | Bridgebio Pharma Inc | 241,119 | 17.1M $ | 1.66 % |
| 20 | Alnylam Pharmaceuticals Inc | 54,138 | 16.8M $ | 1.62 % |
| 21 | Abivax SA | 141,080 | 16.6M $ | 1.60 % |
| 22 | Ionis Pharmaceuticals Inc | 205,400 | 15.4M $ | 1.48 % |
| 23 | Mineralys Therapeutics Inc | 567,545 | 15.1M $ | 1.46 % |
| 24 | EyePoint Inc | 1,123,495 | 14.8M $ | 1.43 % |
| 25 | Eli Lilly & Co | 14,071 | 13.2M $ | 1.27 % |
| 26 | CG oncology Inc | 188,240 | 12.6M $ | 1.21 % |
| 27 | Indivior Pharmaceuticals Inc | 332,496 | 12.2M $ | 1.18 % |
| 28 | Benitec Biopharma Inc | 995,152 | 12M $ | 1.16 % |
| 29 | Arcutis Biotherapeutics Inc | 505,651 | 11.7M $ | 1.13 % |
| 30 | Syndax Pharmaceuticals Inc | 492,743 | 10.6M $ | 1.02 % |
| 31 | Alto Neuroscience Inc | 405,275 | 10.4M $ | 1.00 % |
| 32 | Amylyx Pharmaceuticals Inc | 649,259 | 10.4M $ | 1.00 % |
| 33 | Cytokinetics Inc | 161,063 | 10.3M $ | 0.99 % |
| 34 | BEONE MEDICINES LTD | 33,421 | 9.9M $ | 0.95 % |
| 35 | Tango Therapeutics Inc | 447,635 | 9.7M $ | 0.93 % |
| 36 | Dyne Therapeutics Inc | 519,232 | 9.1M $ | 0.88 % |
| 37 | Solid Biosciences Inc | 1,253,978 | 9.1M $ | 0.88 % |
| 38 | Contineum Therapeutics Inc | 676,121 | 8.7M $ | 0.84 % |
| 39 | Bicara Therapeutics Inc | 387,402 | 8.4M $ | 0.81 % |
| 40 | Vaxcyte Inc | 145,674 | 8.3M $ | 0.80 % |
| 41 | Alkermes PLC | 232,937 | 7.9M $ | 0.76 % |
| 42 | BioNTech SE | 73,400 | 7.6M $ | 0.73 % |
| 43 | Nuvalent Inc | 75,535 | 7.6M $ | 0.73 % |
| 44 | Xenon Pharmaceuticals Inc | 123,767 | 6.9M $ | 0.67 % |
| 45 | ACHIEVE LIFE SCIENCES INC | 1,575,682 | 6.9M $ | 0.67 % |
| 46 | Apogee Therapeutics Inc | 82,737 | 6.9M $ | 0.66 % |
| 47 | ORIC Pharmaceuticals Inc | 659,005 | 6.5M $ | 0.63 % |
| 48 | Structure Therapeutics Inc | 136,424 | 5.7M $ | 0.55 % |
| 49 | Olema Pharmaceuticals Inc | 379,464 | 5.5M $ | 0.53 % |
| 50 | Phathom Pharmaceuticals Inc | 487,012 | 5.5M $ | 0.53 % |
| 51 | Aura Biosciences Inc | 765,617 | 5.4M $ | 0.52 % |
| 52 | Newamsterdam Pharma Co NV | 187,726 | 5.4M $ | 0.52 % |
| 53 | VeraDermics Inc | 53,904 | 5.3M $ | 0.52 % |
| 54 | Inventiva SACA | 969,588 | 5M $ | 0.48 % |
| 55 | Palisade Bio Inc | 2,119,910 | 4.2M $ | 0.41 % |
| 56 | Thermo Fisher Scientific Inc | 8,579 | 4.1M $ | 0.40 % |
| 57 | Kailera Therapeutics Inc | 146,385 | 3.7M $ | 0.35 % |
| 58 | ENGENE THERAPEUTICS INC | 486,579 | 3.5M $ | 0.34 % |
| 59 | uniQure NV | 175,121 | 3.5M $ | 0.34 % |
| 60 | JADE BIOSCIENCES INC | 137,729 | 3.4M $ | 0.32 % |
| 61 | Context Therapeutics Inc | 1,398,833 | 3.3M $ | 0.32 % |
| 62 | Immix Biopharma Inc | 357,034 | 3.2M $ | 0.31 % |
| 63 | Relay Therapeutics Inc | 232,783 | 3M $ | 0.29 % |
| 64 | Satellos Bioscience, Inc. | 343,237 | 2.7M $ | 0.26 % |
| 65 | Ultragenyx Pharmaceutical Inc | 108,067 | 2.7M $ | 0.26 % |
| 66 | GRAIL Inc | 46,433 | 2.5M $ | 0.24 % |
| 67 | SpyGlass Pharma Inc | 109,328 | 2.5M $ | 0.24 % |
| 68 | Ideaya Biosciences Inc | 81,852 | 2.4M $ | 0.23 % |
| 69 | Sionna Therapeutics Inc | 60,891 | 2.4M $ | 0.23 % |
| 70 | Verastem Inc | 401,744 | 2.2M $ | 0.21 % |
| 71 | Acumen Pharmaceuticals Inc | 826,400 | 2M $ | 0.19 % |
| 72 | Artiva Biotherapeutics Inc | 192,871 | 2M $ | 0.19 % |
| 73 | Sartorius Stedim Biotech | 10,100 | 1.9M $ | 0.18 % |
| 74 | Zentalis Pharmaceuticals Inc | 440,039 | 1.8M $ | 0.17 % |
| 75 | Adicet Bio Inc | 225,186 | 1.7M $ | 0.16 % |
| 76 | LENZ Therapeutics Inc | 186,907 | 1.7M $ | 0.16 % |
| 77 | JATT II Acquisition Corp. | 146,753 | 1.5M $ | 0.15 % |
| 78 | BioAge Labs Inc | 90,709 | 1.5M $ | 0.15 % |
| 79 | AVALO THERAPEUTICS INC | 111,577 | 1.5M $ | 0.14 % |
| 80 | Vicore Pharma Holding AB | 1,307,598 | 1.4M $ | 0.14 % |
| 81 | SENSEI BIOTHERAPEUTICS INC | 48,771 | 1.3M $ | 0.13 % |
| 82 | Eikon Therapeutics Inc | 127,376 | 1.2M $ | 0.12 % |
| 83 | Cardiff Oncology Inc | 438,961 | 759.4K $ | 0.07 % |
| 84 | IN8BIO INC | 332,083 | 488.2K $ | 0.05 % |
| 85 | Neumora Therapeutics Inc | 186,984 | 461.9K $ | 0.04 % |
| 86 | ARS Pharmaceuticals Inc | 27,681 | 228.6K $ | 0.02 % |
Sector breakdown
- Health care 32.4 %
- Unattributed 67.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 99.7 %
- EUR 0.2 %
- SEK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 81.8 %
- Ireland 6.6 %
- Netherlands 4.8 %
- France 2.4 %
- United Kingdom 2.0 %
- Canada 1.3 %
- Germany 0.8 %
- Cayman Islands 0.2 %
- Sweden 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 71 | 804M $ | 81.81 % |
| 2 | Ireland | 2 | 65.3M $ | 6.65 % |
| 3 | Netherlands | 3 | 47.1M $ | 4.80 % |
| 4 | France | 3 | 23.4M $ | 2.38 % |
| 5 | United Kingdom | 1 | 19.2M $ | 1.95 % |
| 6 | Canada | 3 | 13.2M $ | 1.34 % |
| 7 | Germany | 1 | 7.6M $ | 0.77 % |
| 8 | Cayman Islands | 1 | 1.5M $ | 0.16 % |
| 9 | Sweden | 1 | 1.4M $ | 0.14 % |
Cite this page
Titelia. "Holdings of Franklin Biotechnology Discovery Fund". https://titelia.com/en/funds/S000006882